Neostigmine
CAS 59-99-4
Overview
Neostigmine is a medication used to treat myasthenia gravis, Ogilvie syndrome, and urinary retention without the presence of a blockage. It is also used together with atropine to end the effects of neuromuscular blocking medication of the non-depolarizing type
Anant Labs manufacture and furnish high quality Neostigmine impurities for global markets. Our Neostigmine EP Impurities are used by API manufacturers and fully integrated pharmaceutical companies worldwide.
Technical Data
CAS59-99-4
Mol. FormulaC12H19N2O2+
Mol. Weight223.296 g/mol
IUPAC[3-(dimethylcarbamoyloxy)phenyl]-trimethylazanium
SMILESCN(C)C(=O)OC1=CC=CC(=C1)[N+](C)(C)C
InChIInChI=1S/C12H19N2O2/c1-13(2)12(15)16-11-8-6-7-10(9-11)14(3,4)5/h6-9H,1-5H3/q+1
InChI KeyALWKGYPQUAPLQC-UHFFFAOYSA-N
Note: We are upgrading our system, Cat No will change.
Synonyms
NEOSTIGMINEEustigminEustigmineProstigmineVagostigmine59-99-4ProstigminNeostigminJuvastigminm-Trimethylammoniumphenyldimethylcarbamate
